The Mayo Research Fellows' Association is an interdisciplinary network of investigators that provides leadership and professional development for early-career researchers at Mayo Clinic.

Contact Dr. Vachon and the Mayo Mammography Health Study about research on mammographic density, breast cancer, hormone therapy and genetic variations in breast cancer risk.

Plastic and reconstructive surgeons at Mayo Clinic offer patients with melanoma comprehensive medical care to meet their reconstructive and cosmetic surgical needs.

Laboratory Medicine and Pathology Mayo Clinic is home to one of the world's largest clinical pathology and laboratory services. Every year, the Department of Laboratory Medicine and Pathology in ...

Must be ≥ 65 years of age and capable of giving signed informed consent, which includes compliance with the requirements and restrictions listed in the ICF and in the protocol, at the time of signing ...

Dr. Lerman's Renovascular Disease Lab at Mayo Clinic studies the development of metabolic syndrome and potential new treatment options.

Contact the Renovascular Disease Lab at Mayo Clinic about clinical studies or research on renovascular disease, cardiorenal interactions and microcirculation.

Multi-Parametric Magnetic Resonance Imaging (MRI) in Kidney and Cardiovascular Disease Magnetic resonance imaging (MRI) is a powerful modality. Functional MRI encompasses a large variety of techniques ...

Learn more about services at Mayo Clinic.Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional ...

Mayo Clinic Office of Postdoctoral Affairs and Research Training enhances the research training experience with career development opportunities.

The Mayo Mammography Health Study is a breast cancer research study at Mayo Clinic that uses features on mammograms to help determine breast cancer risk.

The Nucleic Acid Structure and Recognition Lab at Mayo Clinic studies DNA flexibility, novel DNA-RNA-based drug therapies and rare cancers.